VO
Vivo Opportunity Fund Holdings, L.P. disclosed a 5% stake in AVBP
Vivo Opportunity Fund Holdings, L.P. reported owning 5% of ArriVent BioPharma, Inc. (AVBP) (2,472,701 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 13, 2026
- Source
- Schedule 13G